Scientists are expressing renewed optimism about solving the global organ shortage due to significant advancements in xenotransplantation, the practice of using animal organs in humans. At a recent international conference in Geneva, researchers shared promising data on transplants using organs from genetically modified pigs. These modifications are designed to prevent the human body from rejecting the transplanted animal organs.
Encouraging results have been presented, including two patients in their sixties who have lived for over six months with kidneys from genetically engineered pigs. While one of these patients eventually returned to dialysis after the organ was removed, the extended survival period represents a significant milestone. Furthermore, clinical trials are actively commencing in the United States, with one trial by biotech company United Therapeutics already having transplanted a pig kidney with ten gene edits into its first participant. Th... download the app to read more
YoyoFeed ! Follow top global news sources, read AI-powered summaries, ask AI your questions, translate news into your language, and join live chats — all with YoyoFeed!
